CytoDyn Market Cap

CytoDyn has a market cap or net worth of $268.61 million as of January 23, 2025. Its market cap has increased by 26.26% in one year.

Market Cap

268.61M

Enterprise Value

276.01M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.22

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 268.61M, an increase of 4,750.67%. That is a compound annual growth rate of 22.41%.

Market Cap History

Date	Market Cap	% Change
Jan 23, 2025	268.61M	99.51%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.99B
Veradigm	1.54B
SS Innovations International	1.46B
Nika Pharmaceuticals	603.98M
Elite Pharmaceuticals	526.28M
Glass House Brands	431.12M
Northwest Biotherapeutics	367.83M
BioStem Technologies	264.80M

Market Cap Rankings